$3.51
-0.11-2.90%
At close: -
$3.51
0.000.00%
After Hours: Mar 7, 4:00 PM EDT
Puma Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Puma Biotechnology using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $0.43 | $0.14 | 207.1 % |
Q3 | 2024-11-07 | $0.45 | $0.35 | 28.6 % |
Q2 | 2024-08-01 | $-0.05 | $-0.10 | 50.0 % |
Q1 | 2024-05-02 | $-0.05 | $-0.22 | 77.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-27 | $59.10M | $52.50M | 12.6 % |
Q3 | 2024-11-07 | $80.50M | $70.65M | 13.9 % |
Q2 | 2024-08-01 | $47.10M | $47.30M | -0.42 % |
Q1 | 2024-05-02 | $43.80M | $41.05M | 6.70 % |
Puma Biotechnology (PBYI) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
The Actual EPS was $0.43, which beat the estimate of $0.14.
The Actual Revenue was $59.1M, which beat the estimate of $52.5M.
Browse earnings estimates, EPS, and revenue on all stocks.